Table 3 Overview of Measures and Data Availability for Day 2.
Days | Assessments | Details | n |
---|---|---|---|
Assessment Day 2 | Mood Questionnaire | MDBF (Day 2) | n=218 |
EEG | Raw rs-EEG (Brain Products ActiCaps) | n=217 | |
Preprocessed rs-EEG | n=202 | ||
Digitized EEG channel locations | n=144 | ||
Drug Test | Multi 8/2 Drogentest | n=220 | |
Emotion and Personality Battery | ERQ | n=220 | |
CERQ | n=220 | ||
PSQ | n=220 | ||
TICS | n=220 | ||
COPE | n=219 | ||
LOT-R | n=220 | ||
STAXI | n=220 | ||
NEO-FFI | n=220 | ||
STAI-G-X2 | n=220 | ||
FEV | n=220 | ||
YFAS | n=169 | ||
BIS/BAS | n=220 | ||
UPPS | n=220 | ||
TAS-26 | n=220 | ||
MARS | n=208 | ||
F-SozU K-22 | n=220 | ||
MSPSS | n=220 | ||
TEIQue-SF | n=220 | ||
Psychiatric screening | SCID I | n=219 | |
HAM-D | n=218 | ||
AUDIT | n=219 | ||
BSL-23 | n=169 |